Giovanni Parmigiani, Donald A. Berry, Omar Aguilar 

Slides:



Advertisements
Similar presentations
Estimating the penetrances of breast and ovarian cancer in the carriers of BRCA1/2 mutations Silvano Presciuttini University of Pisa, Italy.
Advertisements

BRCA1/2 Mutation Testing and Breast/Ovarian Cancer in the Ashkenazi Jewish Population Glenn E Palomaki, B.S. Foundation for Blood Research Scarborough,
Ovarian Cancer Risk Reduction Taking oral contraceptives for 5 years can reduce your risk of ovarian cancer by up to 50% Hankinson SE, Colditz GA, Hunter.
BOadicea Antonis Antoniou Cancer Research - UK
Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.
Gene Preference in Maple Syrup Urine Disease Mary M. Nellis, Dean J. Danner The American Journal of Human Genetics Volume 68, Issue 1, Pages (January.
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Evidence for Autosomal Dominant Inheritance of Prostate Cancer
Molecular Analysis of the Breast Cancer Genes BRCA1 and BRCA2 Using Amplicon- Based Massive Parallel Pyrosequencing  Geneviève Michils, Silke Hollants,
Kendy K. Wong, Ronald J. deLeeuw, Nirpjit S. Dosanjh, Lindsey R
Eligibility Criteria and Genetic Testing Results from a High-Risk Cohort for Hereditary Breast and Ovarian Cancer Syndrome in Southeastern Ontario  Ricardo.
Jacek Majewski  The American Journal of Human Genetics 
The APC I1307K Allele and BRCA-Associated Ovarian Cancer Risk
Annotation of Sequence Variants in Cancer Samples
Total-Genome Analysis of BRCA1/2-Related Invasive Carcinomas of the Breast Identifies Tumor Stroma as Potential Landscaper for Neoplastic Initiation 
Annotation of Sequence Variants in Cancer Samples
An Unknown Genetic Defect Increases Venous Thrombosis Risk, through Interaction with Protein C Deficiency  Sandra J. Hasstedt, Edwin G. Bovill, Peter.
Model-Free Linkage Analysis with Covariates Confirms Linkage of Prostate Cancer to Chromosomes 1 and 4  Katrina A.B. Goddard, John S. Witte, Brian K.
High Prevalence of Pathogenic Mutations in Patients with Early-Onset Dementia Detected by Sequence Analyses of Four Different Genes  Ulrich Finckh, Tomas.
Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families  Paul D.P. Pharoah,
CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies 
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined.
Shih-Jen Hwang, Guillermina Lozano, Christopher I. Amos, Louise C
Amy Finch, Ph. D. , Adriana Valentini, M. D. , Ellen Greenblatt, M. D
Molecular Analysis of the Breast Cancer Genes BRCA1 and BRCA2 Using Amplicon- Based Massive Parallel Pyrosequencing  Geneviève Michils, Silke Hollants,
Arpita Ghosh, Fei Zou, Fred A. Wright 
A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer  Pia Vahteristo, Jirina Bartkova, Hannaleena Eerola, Kirsi Syrjäkoski,
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
The decision tree with the two alternatives.
Susan M. Farrington, Juili Lin-Goerke, Jessica Ling, Yute Wang, John D
Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility.
High-Resolution Analysis of Human Y-Chromosome Variation Shows a Sharp Discontinuity and Limited Gene Flow between Northwestern Africa and the Iberian.
Analysis of High-Resolution HapMap of DTNBP1 (Dysbindin) Suggests No Consistency between Reported Common Variant Associations and Schizophrenia  Mousumi.
Are Rare Variants Responsible for Susceptibility to Complex Diseases?
Christoph Lange, Nan M. Laird  The American Journal of Human Genetics 
ATM Mutations and Phenotypes in Ataxia-Telangiectasia Families in the British Isles: Expression of Mutant ATM and the Risk of Leukemia, Lymphoma, and.
Jon Wakefield  The American Journal of Human Genetics 
Multipoint Approximations of Identity-by-Descent Probabilities for Accurate Linkage Analysis of Distantly Related Individuals  Cornelis A. Albers, Jim.
Model-Free Linkage Analysis with Covariates Confirms Linkage of Prostate Cancer to Chromosomes 1 and 4  Katrina A.B. Goddard, John S. Witte, Brian K.
Anne Dørum, Ketil Heimdal, Eivind Hovig, Mats Inganäs, Pål Møller 
E. Warwick Daw, Simon C. Heath, Ellen M. Wijsman 
Claus Skaanning Jensen, Augustine Kong 
Family-Based Tests of Association in the Presence of Linkage
Erratum The American Journal of Human Genetics
Molecular Analysis of the β-Globin Gene Cluster in the Niokholo Mandenka Population Reveals a Recent Origin of the βS Senegal Mutation  Mathias Currat,
Evidence That the Penetrance of Mutations at the RP11 Locus Causing Dominant Retinitis Pigmentosa Is Influenced by a Gene Linked to the Homologous RP11.
Meiotic Microdeletion Breakpoints in the BRCA1 Gene Are Significantly Associated with Symmetric DNA-Sequence Elements  Beatrice Schmucker, Michael Krawczak 
Phylogenetic and Familial Estimates of Mitochondrial Substitution Rates: Study of Control Region Mutations in Deep-Rooting Pedigrees  Evelyne Heyer, Ewa.
Alexander Liede, Imtiaz A
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Identification of Recurrent Mutations in the ARS (Component B) Gene Encoding SLURP-1 in Two Families with Mal de Meleda  Kimberley Morine Ward, Jülide.
Constitutional Mutations of the hSNF5/INI1 Gene Predispose to a Variety of Cancers  Nicolas Sévenet, Eammon Sheridan, Daniel Amram, Pascale Schneider,
Stephen Wooding, Un-kyung Kim, Michael J
by Jennifer Couzin-Frankel
Mapping of the Major Psoriasis-Susceptibility Locus (PSORS1) in a 70-Kb Interval around the Corneodesmosin Gene (CDSN)  Sandro Orrù, Erika Giuressi, Carlo.
Are Variants in the CAPN10 Gene Related to Risk of Type 2 Diabetes
Test for Interaction between Two Unlinked Loci
Mutations in CHEK2 Associated with Prostate Cancer Risk
2010 Presidential Address: Culture: The Silent Language Geneticists Must Learn— Genetic Research with Indigenous Populations  Roderick R. McInnes  The.
A Gene for an Autosomal Dominant Scleroatrophic Syndrome Predisposing to Skin Cancer (Huriez Syndrome) Maps to Chromosome 4q23  Young-Ae Lee, Howard P.
Frequency and Carrier Risk Associated with Common BRCA1 and BRCA2 Mutations in Ashkenazi Jewish Breast Cancer Patients  Flora H. Fodor, Ainsley Weston,
BRCA1 and BRCA2 Testing: Weighing the Demand against the Benefits
Heritability of Cellular Radiosensitivity: A Marker of Low-Penetrance Predisposition Genes in Breast Cancer?  S.A. Roberts, A.R. Spreadborough, B. Bulman,
The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease  Jae Whan Keum, Aram Shin, Tammy Gillis, Jayalakshmi Srinidhi.
Evidence for Autosomal Dominant Inheritance of Prostate Cancer
Alice S. Whittemore, Jerry Halpern 
Quanhe Yang, W. Dana Flanders, Ramal Moonesinghe, John P. A
Risk Prediction of Complex Diseases from Family History and Known Susceptibility Loci, with Applications for Cancer Screening  Hon-Cheong So, Johnny S.H.
Jung-Ying Tzeng, Daowen Zhang  The American Journal of Human Genetics 
Bruce Rannala, Jeff P. Reeve  The American Journal of Human Genetics 
Presentation transcript:

Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2  Giovanni Parmigiani, Donald A. Berry, Omar Aguilar  The American Journal of Human Genetics  Volume 62, Issue 1, Pages 145-158 (January 1998) DOI: 10.1086/301670 Copyright © 1998 The American Society of Human Genetics Terms and Conditions

Figure 1 Cumulative rates of breast cancer (B) and ovarian (O) cancer, for mutation carriers, for (top) BRCA1 (based on Easton et al. 1995) and (bottom) BRCA2 (based on data of D. F. Easton, personal communication). The lines indicate our interpolation, based on a three-parameter gamma c.d.f, with one of the parameters being the asymptote, which may be <1. The American Journal of Human Genetics 1998 62, 145-158DOI: (10.1086/301670) Copyright © 1998 The American Society of Human Genetics Terms and Conditions

Figure 2 Number of breast cancer cases and ovarian cancer cases, for both BRCA1 and BRCA2 carriers and noncarriers. The scales for carriers and noncarriers are different, for better resolution. All else being equal, ovarian cancer is a stronger indication of a mutation than is breast cancer, and earlier-onset breast cancer is a stronger indication than is later-onset breast cancer. The American Journal of Human Genetics 1998 62, 145-158DOI: (10.1086/301670) Copyright © 1998 The American Society of Human Genetics Terms and Conditions

Figure 3 Probability distribution of penetrance functions. Each graph is a sample of 30 penetrance curves. The upper two graphs refer to BRCA1 carriers, and the lower two graphs refer to BRCA2 carriers. Curves are interpreted as in figure 1. The uncertainty about the penetrance of the mutation is captured by variability in the total number of cases at age 80 years. The uncertainty about rates at young ages is high, in relative terms. The American Journal of Human Genetics 1998 62, 145-158DOI: (10.1086/301670) Copyright © 1998 The American Society of Human Genetics Terms and Conditions

Figure 4 Assumed probability distributions of allele mutation frequencies. The unbroken line is the distribution of f1, whereas the broken line is the distribution of f2. The American Journal of Human Genetics 1998 62, 145-158DOI: (10.1086/301670) Copyright © 1998 The American Society of Human Genetics Terms and Conditions

Figure 5 Family history 1 of section 4. Age, when known, is shown for each family member; it is either age at the time of the present study or age at death. The American Journal of Human Genetics 1998 62, 145-158DOI: (10.1086/301670) Copyright © 1998 The American Society of Human Genetics Terms and Conditions

Figure 6 Family history 2 of section 4. Age, when known, is shown for each female family member; it is either her age at the time of the assessment or her age at death. If there is no indication of breast cancer or ovarian cancer, then the family member is free of both. The American Journal of Human Genetics 1998 62, 145-158DOI: (10.1086/301670) Copyright © 1998 The American Society of Human Genetics Terms and Conditions

Figure 7 Probabilistic sensitivity analysis, family 1. Boxplots represent the distribution of the probability that family member 1 of family 1 carries a mutation of BRCA1 or BRCA2, with her age being allowed to change. We are considering the modified version of the pedigree, in which the counseland's father is assumed to have breast cancer and in which the mother is cancer free. Each boxplot is based on the same Monte Carlo sample of size 100. The variability is due to uncertainty in the cancer rates and in the allele frequency. The American Journal of Human Genetics 1998 62, 145-158DOI: (10.1086/301670) Copyright © 1998 The American Society of Human Genetics Terms and Conditions

Figure 8 Probabilistic sensitivity analysis, family 2. Boxplots represent the distribution of the probability that family member 1 of family 2 carries a mutation of BRCA1 or BRCA2, with her age being allowed to change. Each boxplot is based on the same Monte Carlo sample of size 100. The variability is due to uncertainty in the cancer rates and in the allele frequency. The American Journal of Human Genetics 1998 62, 145-158DOI: (10.1086/301670) Copyright © 1998 The American Society of Human Genetics Terms and Conditions

Figure 9 Cumulative risk of breast cancer for a woman with the family history of members 3 and 4 of family 2. The black dots represent predictions based on our model. The letters “C” represent predictions based on the model of Claus et al. (1994). The American Journal of Human Genetics 1998 62, 145-158DOI: (10.1086/301670) Copyright © 1998 The American Society of Human Genetics Terms and Conditions

Figure 10 Probabilistic sensitivity analysis of the cumulative risks breast and ovarian cancer for a woman with the family history of members 3 and 4 of family 2. Each boxplot is based on the same Monte Carlo sample of size 100. The American Journal of Human Genetics 1998 62, 145-158DOI: (10.1086/301670) Copyright © 1998 The American Society of Human Genetics Terms and Conditions